Runze Shang

机构：Huaqiao University, Air Force Medical University · ORCID：0000-0002-7958-0700

发表论文 52 篇 · 总被引 4017 次 · h-index 24

代表论文

• Therapeutic efficacy of FASN inhibition in preclinical models of HCC (2022 · Hepatology · 被引 128)
• Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma (2020 · Gut · 被引 107)
• Long noncoding RNA SLC2A1‐AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway (2020 · Molecular Oncology · 被引 99)
• Oncogene-dependent function of BRG1 in hepatocarcinogenesis (2020 · Cell Death and Disease · 被引 34)
• Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation‐driven hepatocarcinogenesis (2022 · Hepatology · 被引 30)
• Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma (2021 · Cell Death and Disease · 被引 28)